Integrated Quantitative Investments’s Collegium Pharmaceutical COLL Stock Holding History

Integrated Quantitative Investments’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Buy	48,037 +17,024	+55%	+$582K	0.28%	114
2026 Q1	$1.03M	Sell	31,013 -4,443	-13%	-$188K	0.19%	202
2025 Q4	$1.64M	Buy	35,456 +26,921	+315%	+$1.13M	0.35%	75
2025 Q3	$299K	Sell	8,535 -24,490	-74%	-$851K	0.08%	269
2025 Q2	$977K	Sell	33,025 -28	-0.1%	-$799	0.29%	137
2025 Q1	$987K	Sell	33,053 -49	-0.1%	-$1.5K	0.49%	71
2024 Q4	$948K	Buy	+33,102	New	+$1.1M	0.47%	86

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Integrated Quantitative Investments's COLL Position: Q2 2026 in Review

Integrated Quantitative Investments increased its Collegium Pharmaceutical (COLL) stake by 55% in Q2 2026, buying an estimated $582K and bringing the position to 48,037 shares worth $1.74M. The position accounts for 0.28% of the portfolio, ranked #114.

Integrated Quantitative Investments first reported a position in COLL in Q4 2024 and has held it in 7 quarters since. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Integrated Quantitative Investments held 48,037 shares of Collegium Pharmaceutical worth $1.74M as of Q2 2026.
Integrated Quantitative Investments bought 17,024 Collegium Pharmaceutical shares in Q2 2026, an estimated $582K.
Collegium Pharmaceutical made up 0.28% of Integrated Quantitative Investments's portfolio in Q2 2026, its #114 holding.
Integrated Quantitative Investments first reported a position in Collegium Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.